1. Home
  2. NCSM vs ATYR Comparison

NCSM vs ATYR Comparison

Compare NCSM & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCS Multistage Holdings Inc.

NCSM

NCS Multistage Holdings Inc.

HOLD

Current Price

$39.01

Market Cap

97.3M

Sector

Energy

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.72

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCSM
ATYR
Founded
2006
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.3M
79.2M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
NCSM
ATYR
Price
$39.01
$0.72
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$8.75
AVG Volume (30 Days)
14.6K
2.0M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.53
N/A
Revenue
$178,000,000.00
$190,000.00
Revenue This Year
$11.25
N/A
Revenue Next Year
$7.76
$18,728.88
P/E Ratio
$8.82
N/A
Revenue Growth
16.49
N/A
52 Week Low
$23.89
$0.64
52 Week High
$53.69
$7.29

Technical Indicators

Market Signals
Indicator
NCSM
ATYR
Relative Strength Index (RSI) 47.78 41.75
Support Level $39.00 $0.70
Resistance Level $40.69 $0.85
Average True Range (ATR) 1.51 0.05
MACD -0.20 0.01
Stochastic Oscillator 13.36 19.29

Price Performance

Historical Comparison
NCSM
ATYR

About NCSM NCS Multistage Holdings Inc.

NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

Share on Social Networks: